300436 Stock Overview
Engages in the research and development, manufacture, and sale of pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Fujian Cosunter Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥31.80 |
| 52 Week High | CN¥37.96 |
| 52 Week Low | CN¥14.16 |
| Beta | 0.87 |
| 1 Month Change | 14.93% |
| 3 Month Change | 37.36% |
| 1 Year Change | 24.07% |
| 3 Year Change | -33.79% |
| 5 Year Change | -5.41% |
| Change since IPO | 105.69% |
Recent News & Updates
Does Fujian Cosunter Pharmaceutical (SZSE:300436) Have A Healthy Balance Sheet?
Sep 30
Optimistic Investors Push Fujian Cosunter Pharmaceutical Co., Ltd. (SZSE:300436) Shares Up 27% But Growth Is Lacking
Sep 30Fujian Cosunter Pharmaceutical Co., Ltd.'s (SZSE:300436) Shares Climb 34% But Its Business Is Yet to Catch Up
Aug 12Recent updates
Does Fujian Cosunter Pharmaceutical (SZSE:300436) Have A Healthy Balance Sheet?
Sep 30Optimistic Investors Push Fujian Cosunter Pharmaceutical Co., Ltd. (SZSE:300436) Shares Up 27% But Growth Is Lacking
Sep 30Fujian Cosunter Pharmaceutical Co., Ltd.'s (SZSE:300436) Shares Climb 34% But Its Business Is Yet to Catch Up
Aug 12Some Fujian Cosunter Pharmaceutical Co., Ltd. (SZSE:300436) Shareholders Look For Exit As Shares Take 28% Pounding
Apr 16Shareholder Returns
| 300436 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 4.2% | -1.9% | -0.6% |
| 1Y | 24.1% | -5.7% | 8.3% |
Return vs Industry: 300436 exceeded the CN Pharmaceuticals industry which returned -5.7% over the past year.
Return vs Market: 300436 exceeded the CN Market which returned 8.3% over the past year.
Price Volatility
| 300436 volatility | |
|---|---|
| 300436 Average Weekly Movement | 14.6% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.9% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300436's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300436's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 908 | Guoping Li | www.cosunter.com |
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers medicines for anti-HBV, liver diseases, digestive, respiratory, cardiovascular, men’s health, and other fields. The company primarily produces crude drug and solid preparation in the forms of tablet, capsule, granule, medicinal tea, etc. Fujian Cosunter Pharmaceutical Co., Ltd.
Fujian Cosunter Pharmaceutical Co., Ltd. Fundamentals Summary
| 300436 fundamental statistics | |
|---|---|
| Market cap | CN¥5.06b |
| Earnings (TTM) | -CN¥223.40m |
| Revenue (TTM) | CN¥469.34m |
10.8x
P/S Ratio-22.7x
P/E RatioIs 300436 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300436 income statement (TTM) | |
|---|---|
| Revenue | CN¥469.34m |
| Cost of Revenue | CN¥197.19m |
| Gross Profit | CN¥272.15m |
| Other Expenses | CN¥495.56m |
| Earnings | -CN¥223.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.40 |
| Gross Margin | 57.99% |
| Net Profit Margin | -47.60% |
| Debt/Equity Ratio | 89.7% |
How did 300436 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 19:57 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Fujian Cosunter Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |